AIM ImmunoTech Inc. (0A4Y)
LSE
0.2540
-0.0021 (-0.84%)
Closed
Aug 25, 2026
Day's Range
0.24990.2540
52 wk Range
0.22263.32
Financial Statements - 0A4Y - AIM ImmunoTech Inc.
Revenue
80.47M▲ 43.8%
Net Income
3.28M▼ 42.3%Net Margin 4.1%
EBITDA
7.18M▼ 6.0%
Free Cash Flow
3.66M▲ 39.9%
Income Statement
| Period Ending | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|
| Sales | 80.47M | 55.98M | 31.50M | 31.24M |
| Cost of Goods | 64.58M | 44.06M | 26.38M | 25.41M |
| Gross Profit | 15.89M | 11.92M | 5.11M | 5.83M |
 Operating Expense | - | - | - | - |
| Operating Income | 6.31M | 6.76M | 714K | 1.40M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 3.76M | 7.15M | 876K | 1.44M |
| Income Tax | 477K | 1.45M | 158K | 262K |
| Net Income | 3.28M | 5.69M | 718K | 1.18M |
| EPS Basic | 0.0322 | 0.054274 | 0.006841 | 0.011263 |
| EPS Diluted | 0.0322 | 0.054274 | 0.006841 | 0.011263 |
| Basic Shares Outstanding | 101.97M | 104.94M | 104.94M | 104.94M |
| Diluted Shares Outstanding | 101.97M | 104.94M | 104.94M | 104.94M |
| Ebit | - | - | - | - |
| Ebitda | 7.18M | 7.65M | 1.37M | 1.85M |
| Net Income Continuous Operations | 3.28M | 5.69M | 718K | 1.18M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
